YÜKSEL, M. Et Al. 2013. A novel conditoning regimen for primary CNS lymphoma: high dose rituximab, cyclophosphamide, etoposide and BCNU (RCVB). 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT) , (London, Canada).

YÜKSEL, M., Tek, I., Koktas, O., Kurdal, M., TOPRAK, S. K., Ilhan, O., ... Arslan, O.(2013). A novel conditoning regimen for primary CNS lymphoma: high dose rituximab, cyclophosphamide, etoposide and BCNU (RCVB) . 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, Canada

YÜKSEL, MELTEM Et Al. "A novel conditoning regimen for primary CNS lymphoma: high dose rituximab, cyclophosphamide, etoposide and BCNU (RCVB)," 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, Canada, 2013

YÜKSEL, MELTEM Et Al. "A novel conditoning regimen for primary CNS lymphoma: high dose rituximab, cyclophosphamide, etoposide and BCNU (RCVB)." 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT) , London, Canada, 2013

YÜKSEL, M. Et Al. (2013) . "A novel conditoning regimen for primary CNS lymphoma: high dose rituximab, cyclophosphamide, etoposide and BCNU (RCVB)." 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT) , London, Canada.

@conferencepaper{conferencepaper, author={MELTEM YÜKSEL Et Al. }, title={A novel conditoning regimen for primary CNS lymphoma: high dose rituximab, cyclophosphamide, etoposide and BCNU (RCVB)}, congress name={39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT)}, city={London}, country={Canada}, year={2013}}